The 2023 San Antonio Breast Cancer Symposium featured five days of research presentations, educational sessions, and advocacy meetings. Dr. Matthew Goetz, noted breast cancer researcher at the Mayo Clinic, explained the top research presented that will make an immediate difference for people diagnosed with breast cancer. Listen to the podcast to hear Dr. Goetz explain: a study on inavolisib, a promising new treatment for advanced-stage, hormone receptor-positive breast cancer that’s stopped responded to tamoxifen or an aromatase inhibitor how the immunotherapy medicines Keytruda (chemical name: pembrolizumab) and Opdivo (chemical name: nivolumab) can be used to treat early-stage, triple-negative breast cancer overall survival results from the MONARCH-3 study on Verzenio (chemical name: abemaciclib) why overall survival is such an important study end point

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related